Comparative efficacy of 1% sodium alendronate gel V/s cissusquadrangularis capsules on stability and crestal bone loss of dental implants : A randomized control trial.
- Conditions
- Health Condition 1: K081- Complete loss of teethHealth Condition 2: K084- Partial loss of teeth
- Registration Number
- CTRI/2023/09/057185
- Lead Sponsor
- Dr Ankita Chhabrani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients being in need of at least one dental implant.
2. Patients exhibiting adequate bone quality and quantity,
3. Have had extractions done at least 3 months prior to implant placement.
4.Consenting patients who are cooperative and able to come for regular follow up.
1. Untreated caries and/or periodontal disease of residual dentition.
2. History of pain in TMJ.
3. Patients who will undergo occlusal adjustments therapy, composite restorations, orthodontic treatment, extraction.
4. Need for presurgical bone and soft tissue augmentation in the planned implant area.
5. Any systemic or local disease or condition, & under medication that would compromise postoperative healing and or osseointegration.
6. Present alcohol or drug abuse.
7. Current use of smoke or smokeless forms of tobacco.
8. Pregnancy or lactation at the time of enrollment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the clinical and radiographical parameters around implants.Timepoint: Baseline, post- implant placement, 2,4,8,12th week
- Secondary Outcome Measures
Name Time Method To compare the implant stability quotient in all groups.Timepoint: Baseline, post- implant placement, 2,4,8,12th week